David A. Zilberberg

Davis Polk advised the underwriters in connection with an SEC-registered offering by AbbVie Inc. of €1.4 billion aggregate principal amount of senior notes in two series, consisting of €750…

Davis Polk advised the joint lead arrangers and joint bookrunners and the administrative agent, in connection with a $2.425 billion senior secured credit facility to II-VI…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by Spectrum of $300 million aggregate principal amount of its 5.00% senior notes due 2029…

Davis Polk advised the joint bookrunners in connection with an offering by PerkinElmer, Inc. of $850 million aggregate principal amount of its 3.300% notes due 2029. Headquartered in…

Davis Polk acted as counsel to the underwriter, forward seller and forward purchaser in connection with the execution of a forward sale agreement with HL1 17 LP (the “Selling Shareholder”),…

Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Deciphera Pharmaceuticals, Inc. of 10,810,810 shares of common stock for gross proceeds…

Davis Polk advised the underwriter, forward seller and forward purchaser in connection with the execution of a forward sale agreement with HL1 17 LP (the “Selling Shareholder”), an…

Davis Polk advised the administrative agent, joint lead arranger and joint bookrunner in connection with a $925 million first-lien term loan facility and a $150 million asset-based…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $600 million aggregate principal amount of its 2.150%…

Davis Polk advised the underwriters in connection with the debut SEC-registered notes offering by Las Vegas Sands Corp. of $1.75 billion of its 3.200% senior notes due 2024, $1 billion…